These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 15146288)

  • 1. [Infectious diseases-Part II: New agents, resistances, and treatment strategies].
    Salzberger B; Franzen C; Glück T
    Med Klin (Munich); 2004 May; 99(5):251-60. PubMed ID: 15146288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of corticosteroids in treating infectious diseases.
    McGee S; Hirschmann J
    Arch Intern Med; 2008 May; 168(10):1034-46. PubMed ID: 18504331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fishing for new antimicrobials.
    Mukhopadhyay A; Peterson RT
    Curr Opin Chem Biol; 2006 Aug; 10(4):327-33. PubMed ID: 16822704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The case for pathogen-specific therapy.
    Casadevall A
    Expert Opin Pharmacother; 2009 Aug; 10(11):1699-703. PubMed ID: 19558338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial stewardship.
    Fishman N
    Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S55-63; discussion S64-73. PubMed ID: 16813983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tigecycline: first of a new class of antimicrobial agents.
    Rose WE; Rybak MJ
    Pharmacotherapy; 2006 Aug; 26(8):1099-110. PubMed ID: 16863487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial resistance: international control strategies, with a focus on limited-resource settings.
    Diazgranados CA; Cardo DM; McGowan JE
    Int J Antimicrob Agents; 2008 Jul; 32(1):1-9. PubMed ID: 18550343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and antibiotic therapy of infections in outpatients].
    Stürchler MS; Vuille P; Zemp E; Tschudi P; Zimmerli W
    Schweiz Med Wochenschr; 2000 Oct; 130(41):1437-46. PubMed ID: 11075407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoting appropriate antimicrobial drug use: perspective from the Centers for Disease Control and Prevention.
    Bell DM
    Clin Infect Dis; 2001 Sep; 33 Suppl 3():S245-50. PubMed ID: 11524727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Infectious agents : current concepts and perspectives].
    Pijck J; Vuye A
    Ann Biol Clin (Paris); 1983; 41(6):383-92. PubMed ID: 6364898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Importance of the antimicrobial spectrum and the bacterial resistances in the antibiotic choice for the treatment of pediatric patients with communitary infections].
    Baquero F; González J; Martínez D; Olmo V; Orero A; Prieto J;
    Rev Esp Quimioter; 2009 Mar; 22(1):38-47. PubMed ID: 19308746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Microbial spectrum in surgical infections based on a microbiological routine monitoring over the 10-year period from 1995 to 2004].
    Mroczkowski P; Lauf H; Lippert H; König W; Meyer F
    Zentralbl Chir; 2009 Jun; 134(3):226-30. PubMed ID: 19536716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of the antimicrobial agent susceptibility study raised in a representative, cross-sectional monitoring study on a national basis.
    Kaspar H
    Int J Med Microbiol; 2006 Jun; 296 Suppl 41():69-79. PubMed ID: 16531116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discontinued drugs in 2008: anti-infectives.
    Ryder NS
    Expert Opin Investig Drugs; 2010 Jan; 19(1):1-21. PubMed ID: 20001552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fighting infections due to multidrug-resistant Gram-positive pathogens.
    Cornaglia G
    Clin Microbiol Infect; 2009 Mar; 15(3):209-11. PubMed ID: 19335367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antimicrobial resistance containment and surveillance approach--a public health tool.
    Simonsen GS; Tapsall JW; Allegranzi B; Talbot EA; Lazzari S
    Bull World Health Organ; 2004 Dec; 82(12):928-34. PubMed ID: 15654407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The current state of infectious disease: a clinical perspective on antimicrobial resistance.
    Shay LE; Freifeld AG
    Lippincotts Prim Care Pract; 1999; 3(1):1-15; quiz 16-8. PubMed ID: 10214199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical challenges in addressing resistance to antimicrobial drugs in the twenty-first century.
    Septimus EJ; Kuper KM
    Clin Pharmacol Ther; 2009 Sep; 86(3):336-9. PubMed ID: 19571803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinatorial immunotherapies for infectious diseases.
    Hengel H; Masihi KN
    Int Immunopharmacol; 2003 Aug; 3(8):1159-67. PubMed ID: 12860171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.